-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The 2019 new coronary pneumonia ( COVID-19 ) will disrupt vascular endothelial function, but it is not clear whether COVID-19 will also affect arterial stiffness.
Coronavirus disease
Recently, an authoritative journal in the field of internal medicine published a research article in the Journal of Internal Medicine.
The researchers compared 22 COVID-19 patients (50% were female patients, with an average age of 77 [67-84] years) with 22 age- and gender-matched controls.
Among COVID-19 patients, baPWV (19.
It can be seen that COVID-19 seems to be related to the increase of PWV, indicating that the arterial stiffness of these patients has increased.
COVID-19 seems to be associated with an increase in PWV, indicating that these patients have increased arterial stiffness.
Original source:
Bertil Lindahl.
wiley.
com/doi/10.
1111/joim.
13272" target="_blank" rel="noopener">Poor long-term prognosis in patients admitted with strong suspicion of acute myocardial infarction but discharged with another diagnosis in this message